Lu Kang Medical (600789.SH): Azithromycin tablets pass the generic drug consistency evaluation.

Zhixin Finance APP News, Lu Kang Pharmaceuticals (600789.SH) announced that recently, the company's controlling subsidiary Shandong Lu Kang Pharmaceuticals Group Saite Limited Liability Company ("Saite Company") received the "Drug Supplementary Application Approval Notice" (Approval Number: 2025B02344) issued by the National Medical Products Administration for the consistency evaluation of generic drug quality and efficacy of azithromycin tablets.